Intel: Chips Act subsidies may impede a return to former glory - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Intel: Chips Act subsidies may impede a return to former glory

US government funds risk reducing pressure on semiconductor group to improve its performance

The US has embarked on an ambitious and expensive project: rebooting a domestic manufacturing industry for leading-edge chips. A downturn in demand ratchets up the pressure.

Intel imagines the push will help it regain global dominance. It would not be the first time the hopes of the US chip giant have exceeded its prospects.

The US Chips Act puts more than $52bn up for grabs via a mishmash of loans, guarantees for third parties and direct funding. Money will arrive in the coming months.

Intel is expected to be one of the biggest beneficiaries. But semiconductor companies jostling for funds are aiming at a moving target. The US government has introduced extra conditions, including childcare provision and limiting investment in Chinese entities. Funds cannot be spent on buybacks and dividends. Some projects will need to share profits. 

Intel can find ways to tick those boxes. It helps that the US wants projects that contribute to America’s national security and reduce dependence on chips made in Taiwan. Unlike rival AMD, Intel designs and makes chips. 

Yet Intel’s stock is down 24 per cent since the Chips Act was signed into law last August. Falling demand for semiconductors is only one reason for this. The share price of rival AMD is down 15 per cent over the same period. 

Intel has a large, cumbersome corporate structure, reflecting its range of legacy businesses. It does not produce leading-edge chips. Last year, revenue fell by a fifth. It is expected to drop by the same amount this year. Net income margin has halved.

The company is, meanwhile, increasing capital spending to pay for new factories and designs. The figure is expected to climb from about 20 per cent of sales five years ago to the “low 30s” this year. Last month, Intel cut its dividend by two-thirds.

AMD’s net income margin has also fallen. Semiconductor demand is readjusting following high spending during the pandemic. But AMD has less onerous capex obligations. Its new Ryzen chips boast artificial intelligence capabilities. Margins are forecast to return to 21 per cent this year.

Subsidies have a tendency to reduce competitiveness rather than increase it. They could simply reduce pressure on Intel to improve its performance. If money was essential for a turnround, it should have started 10 years ago, when Intel was sitting on more cash than its rivals.

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

中东期待沙特阿拉伯制衡特朗普

阿拉伯国家希望穆罕默德王储和美国当选总统特朗普的密切关系能够缓和特朗普政府的中东政策。

投资者押注防务支出增加,Palantir成为“特朗普交易”赢家之一

彼得•蒂尔创立的数据公司的最大客户是美国政府,自特朗普本月当选以来,其市值增加了230亿美元。

Lex专栏:增长来之不易,雀巢前景平淡

要实现其增长目标,这家瑞士集团需要增加营销投资。

Lex专栏:便宜商品是沃尔玛股价上涨的基础

沃尔玛通过吸引高收入顾客和增加其他收入来源,出色地应对了经济不景气和通胀带来的挑战。

Lex专栏:奢侈品品牌寄希望于自己的美国梦

奢侈品在美国越来越具有吸引力,可能为该行业提供新的增长跑道。

诺和诺德准备下一代减肥药的试验结果

这家丹麦公司预计,最新数据将显示CagriSema可在一年多的时间内减轻25%的体重。
设置字号×
最小
较小
默认
较大
最大
分享×